Journal of Hospice and Palliative Care

Korean Society for Hospice and Palliative Care (한국호스피스완화의료학회)
권호 표지

Palliative Radiotherapy

증상완화목적의 방사선치료

  • Lee, Chang-Geol (Department of Radiation Oncology, Gangnam Severance Hospital, Yonsei University College of Medicine)
  • 이창걸 (연세대학교 의과대학 강남세브란스병원 방사선종양학과)
  • Published : 2009.03.01
Download PDF
⟨ Previous Next ⟩

Abstract

The aim of palliative radiotherapy (RT) is to control cancer-related local symptoms with minimal radiation reaction. About one third of all radiation treatments are given with palliative intent. Indications for RT in symptom palliation are as follows: Pain from bone metastasis, pressure symptom from brain and spinal cord, obstruction of bronchus, esophagus, superior vena cava and malignant cancer bleeding from bronchus, urinary tract, uterine cervix and rectum. In hospice palliative care, RT is very effective for symptom palliation and improvement of quality of life without influence on survival.

방사선치료의 목적은 완치목적 그리고 증상완화목적 두 가지로 나뉜다. 전체 암환자의 약 45%는 방사선치료를 받으며 이중 25${\sim}$30%는 증상완화목적의 치료를 받고있다. 방사선치료는 비록 생존기간의 연장에는 영향을 미치지 않으나 증상완화효과는 대단히 우수하며 임종시까지 삶의 질을 유지하는데 큰 역할을 한다. 증상완화 방사선치료의 적응증으로는 골전이에 의한 통증, 뇌전이, 척수압박으로 인한 신경학적 증상, 암으로 인한 기관지, 식도, 상대정맥 폐쇄 증상, 기관지, 비뇨생식기계 직장의 암성출혈 등이다. 이 중 골전이에 대한 치료가 가장 흔한 적응증이며 통증조절 외에 병적골절예방 및 척수압박예방의 효과를 가지며 약 70${\sim}$80%의 증상 완화효과를 나타낸다.

Keywords

References

  1. Hoskin PJ. Radiotherapy in symptom management. In: Doyle D, Hanks G, Cherny N, Calman K, eds. Oxford textbook of palliative medicine. 3rd ed. New York: Oxford University Press; 2004. p. 239-55.
  2. Hartsell WF. Yajni santosh. Palliation of bone metastasis. In Halperin EC. Perez CA. Brady LW, eds. Perez and Brady's principles and practice of radiation oncology. 5th ed. Lippincott Williams & Wilkins; 2007. p. 1986-99.
  3. Steenland E, Leer JW, van Houwelingen H, Post WJ, van den Hout WB, Kievit J, et al. The effect of single fraction compared to multiple fractions on painful bone metastases: a global analysis of the Dutch Bone Metastasis Study. Radiother Oncol 1999; 52(2):101-9. https://doi.org/10.1016/S0167-8140(99)00110-3
  4. Salazar OM, Rubin P, Hendrickson FR, Komaki R, Poulter C, Newall J, et al. Single-dose half-body irradiation for palliation of multiple bone metastases from solid tumors: final Radiation Therapy Oncology Group report. Cancer 1986;58(1):29-36. https://doi.org/10.1002/1097-0142(19860701)58:1<29::AID-CNCR2820580107>3.0.CO;2-2
  5. Mirels H. Metastatic disease in long bones: a proposed scoring system for diagnosing impending pathologic fractures. Clin Orthop Relat Res 1989;249:256-64.
  6. Scarantino CW, Caplan R, Rotman M, Coughlin C, Demas W, Delrowe J. A phase I/II study to evaluate the effect of fractionated hemibody irradiation in the treatment of osseous bone metastases: RTOG 88-22. Int J Radiat Oncol Biol Phys 1996;36(1):37-48. https://doi.org/10.1016/S0360-3016(96)00247-7
  7. Tennvall J, Darte L, Lundgren R, el Hassan AM. Palliation of multiple bone metastases from prostatic carcinoma with strontium- 89. Acta Oncol 1988;27(4):365. https://doi.org/10.3109/02841868809093556
  8. Lee IJ, Seong J, Lee CG, Kim YB, Chang Keum K, Suh CO, et al. Early clinical experience and outcome of helical tomotherapy for multiple metastatic lesions. Int J Radiat Oncol Biol Phys 2008 Dec 10 (in press).